Purchases and Sales Made in Q1 2024 in Autolus Therapeutics PLC (AUTL)
This table provides information about the institutional ownership of Autolus Therapeutics PLC (AUTL) during Q1 2024. The information is specifically focused on institutions that hold shares of Autolus Therapeutics plc.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Dec 26, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-1.16M- 89.97% |
$6.23M - $8.43M
|
129K
$263K
|
|
Oct 17, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-2.21M- 76.23% |
$11.9M - $16.1M
|
690K
$1.41M
|
|
May 15, 2024
Q1 2024
|
Paradigm Biocapital Advisors LP
New York, NY |
SELL
|
- |
-6.19M- 49.05% |
$33.3M - $45.1M
|
6.43M
$13.1M
|